Technology Solutions

Roche app measures Parkinson’s disease fluctuations

Monday, August 17, 2015

Roche Pharma Research & Early Development (pRED) has developed a smartphone-based monitoring system for those with Parkinson’s disease (PD) that complements the traditional physician-led assessments with automated tests that continuously measure their symptom fluctuations. It could be the first time that such an app has been used to measure disease and symptom severity in a medicine development program in PD.

[Read More]

Early inroads for wearable devices in clinical trials

Saturday, August 15, 2015

It is nearly impossible today to avoid the growing number of commercially available wearable devices capable of gathering health information. These devices—typically placed on a wrist, arm or chest—hold promise for col­lecting, transmitting and integrating objective experiential data in real time and in aiding the analysis of a much higher volume of data from a significantly larger number of patients. But based on interviews with industry profession­als, the conceptual promise of wearable devices in clinical trials remains largely that. Adoption is in its very earliest stages.

[Read More]

BRANY launches new license option for Protocol Builder

Friday, August 14, 2015

Protocol Builder, a cloud-based solution for investigator-initiated clinical trials, now is available to individual researchers, including medical residents and fellows, according to the Biomedical Research Alliance of New York (BRANY), the developer of the system and a national organization providing clinical research support solutions such as IRB review, trial contracting/budgeting, and auditing and monitoring to hospitals and academic medical centers.

[Read More]

Roche acquires GeneWEAVE

Thursday, August 13, 2015

Roche has signed a definitive agreement to acquire GeneWEAVE BioSciences, a Los Gatos, Calif.-based, privately held company focused on clinical microbiology diagnostics solutions. Roche will pay GeneWEAVE shareholders $190 million upfront and up to $235 million in contingent product related milestones. The transaction is subject to customary closing conditions and, once closed, GeneWEAVE will be integrated into Roche Molecular Diagnostics.

[Read More]

Survey: Industry will move toward RBM adoption

Wednesday, August 12, 2015

OmniComm Systems, a global provider of clinical data management technology, has announced survey results representing clinical research and development organizations. The survey respondents included 16 sponsor organizations and 13 CROs. The results indicate a significant movement forward in the industry toward active risk-based monitoring (RBM) adoption, with 76% of the organizations reporting that they are either already executing RBM studies (45%) or planning to initiate RBM studies during this year (31%).

[Read More]

CRF Health launches eCOA solution for oncology trials

Wednesday, August 12, 2015

CRF Health, a Plymouth Meeting, Pa.-based global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, has launched a complete TrialMax eCOA solution specifically for oncology clinical trials. Developed based on CRF Health’s experience of delivering more than 100 global oncology studies, the solution streamlines data collection by combining an eCOA capture system with intuitive site and patient management tools. Reporting concomitant medication data also is simplified, enabling sponsors to collect complete data while reducing patient and investigator burden.

[Read More]

Algorithm changes name, updates acuity solution

Monday, August 10, 2015

Algorithm, a global provider of clinical analytics solutions and software, has released the latest version of its acuity solution, designed for use by pharma, biotech, CRO and academic organizations to drive regulatory compliant processes around management of risk. The acuity solution allows organizations to assess and capture the risk profile for a clinical trial and map risks to intelligent actions as part of the risk-based monitoring paradigm.

[Read More]

iCardiac acquires nSpire Health’s clinical trials division

Thursday, August 6, 2015

iCardiac Technologies, a Rochester, N.Y.-based global provider of cardiac safety assessment services to the pharmaceutical industry, has added respiratory and ePRO services to its suite of offerings through the acquisition of the clinical trials division of nSpire Health. iCardiac also has opened a new office in Longmont, Colo., to accommodate the project management, data management, customer support, IT, technology development and business development teams joining iCardiac from nSpire Health.

[Read More]